George Mastorakos

Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1998, The Journal of clinical endocrinology and metabolism.

Peptide Hormone Analysis in Diagnosis and Treatment of Differences of Sex Development: Joint Position Paper of EU COST Action "DSDnet" and European Reference Network on Rare Endocrine Conditions.

K. Main, S. Ahmed, A. Juul, 2020, European journal of endocrinology.

Effect of endocrine disruptors on male reproduction in humans: why the evidence is still lacking?

G. Mastorakos, G Mastorakos, D G Goulis, 2017, Andrology.

Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1999, The Journal of clinical endocrinology and metabolism.

Antioxidant agents in the treatment of Graves' ophthalmopathy.

D. Koutras, G. Mastorakos, E. Bouzas, 2000, American journal of ophthalmology.

Maternal Hypothalamic‐Pituitary‐Adrenal Axis in Pregnancy and the Postpartum Period: Postpartum‐Related Disorders

I. Ilias, G. Mastorakos, Ioannis Ilias, 2000, Annals of the New York Academy of Sciences.

DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview.

T. Tzotzas, D. Rachoń, T. Tsilchorozidou, 2019, European journal of endocrinology.

Presence of metabolic risk factors in non-obese PCOS sisters: Evidence of heritability of insulin resistance

E. Diamanti-Kandarakis, H. Kandarakis, G. Mastorakos, 2004, Journal of endocrinological investigation.

Effects of severity of chronic obstructive pulmonary disease on thyroid function.

I. Dimopoulou, I. Ilias, D. Koutras, 2001, Metabolism: clinical and experimental.